tyrosine has been researched along with Cancer of Gallbladder in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujishima, H; Masumoto, N; Nakano, S; Niho, Y; Tatsumoto, T | 1 |
| Date, K; Kuba, K; Matsumoto, K; Nakamura, T; Shimura, H; Tanaka, M | 1 |
2 other study(ies) available for tyrosine and Cancer of Gallbladder
| Article | Year |
|---|---|
Interferon-alpha and -gamma inhibit the growth and neoplastic potential of v-src-transformed human epithelial cells by reducing Src tyrosine kinase activity.
Topics: Adenocarcinoma; Antineoplastic Agents; Cell Line, Transformed; Epithelial Cells; Gallbladder Neoplasms; Genes, ras; Genes, src; Humans; Interferon-alpha; Interferon-gamma; Phosphorylation; Protein-Tyrosine Kinases; src-Family Kinases; Transfection; Tyrosine | 1998 |
Inhibition of tumor growth and invasion by a four-kringle antagonist (HGF/NK4) for hepatocyte growth factor.
Topics: Aged; Animals; Female; Gallbladder Neoplasms; Hepatocyte Growth Factor; Humans; Kringles; Male; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Mice; Mice, Nude; Middle Aged; Neoplasm Invasiveness; Neoplasm Transplantation; Phosphorylation; Proto-Oncogene Proteins c-met; Tumor Cells, Cultured; Tyrosine; Urokinase-Type Plasminogen Activator | 1998 |